Treating hypertension in type II diabetic patients with device-guided breathing: A randomized controlled trial

Journal of Human Hypertension

Volumn 23, Issue 5, 2009, Pages 325-331

  Schein, M H ^a   Gavish, B ^b   Baevsky, T ^c   Kaufman, M ^d   Levine, S ^c   Nessing, A ^c   Alter, A ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b InterCure Ltd   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d Leumit Health Care System   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C; RESPERATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASSISTIVE TECHNOLOGY DEVICE; BLOOD PRESSURE REGULATION; BODY MASS; BREATHING EXERCISE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE THERAPY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; FEMALE; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISRAEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SYSTOLIC BLOOD PRESSURE;

AGED; BREATHING EXERCISES; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MIND-BODY THERAPIES; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 67349222979     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.135     Document Type: Article

References (40)

1. The Hypertension in Diabetes Study Group. 1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. Hypertension in Diabetes Study (HDS). J Hypertension 1993; 11: 309-317.
2. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-418.
3. Fuller JH. Epidemiology of hypertension associated with diabetes mellitus. Hypertension 1985; 7(6 Part 2): II3-II7.
4. Bild D, Teutsch SM. The control of hypertension in persons with diabetes: A public health approach. Public Health Rep 1987; 102 522-529.
5. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427-2432.
6. Hasslacher C, Ritz E, Terpstra J, Gallasch G, Kunowski G, Rall C. Natural history of nephropathy in type 1 diabetes: Relationship to metabolic control and blood pressure. Hypertension 1985; 7(6 Part 2): II74-II78.
7. Working Group Report on Hypertension in Diabetes. National High Blood Pressure Education Program. National Institutes of Health: Bethesda, MD, 1994; NIH publication no. 94-3530.
8. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252.
9. Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertension 2003; 21: 1011-1053.
10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 29: S4-S36.
11. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. BMJ 1998; 317: 703-713.
12. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Stevo J et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (Hot) randomized trial. Lancet 1998; 351: 1755-1762.
13. Basile JN, Lackland DT, Basile JM, Riehle JE, Egan BM. A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypert 2004; 6: 18-25.
14. Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-342.
15. Bengtsson C, Blohme G, Lapidus L, Lindquist O, Lundgren H, Nystrom E et al. Do antihypertensive drugs precipitate diabetes? BMJ 1984; 289: 1495-1497.
16. Schein MH, Gavish B, Herz M, Rosner-Kahana D, Naveh P, Knishkowy B et al. Treating hypertension with a device that slows and regularizes breathing: A randomized, double-blind controlled study. J Hum Hypertens 2001; 15: 271-278.
17. Grossman E, Grossman A, Schein MH, Zimlichman R, Gavish B. Breathing control lowers blood pressure. J Hum Hypertens 2001; 15: 263-269.
18. Rosenthal T, Alter A, Peleg E, Gavish B. Device-guided breathing exercises reduce blood pressure: Ambulatory and home measurements. Am J Hypertens 2001; 14: 74-76.
19. Viskoper R, Shapira I, Priluck R, Mindlin R, Chornia L, Laszt A et al Non-pharmacological treatment of resistant hypertensives by device-guided slow breathing exercises. Am J Hypertension 2003; 16: 484-487.
20. Elliott WJ, Izzo JL, White WB, Rosing DJ, Snyder CS, Alter A et al Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens 2004; 6: 553-561.
21. Meles E, Giannattasio C, Faila M, Gentile G, Capra A, Mancia G. Non-pharmacologic treatment of hypertension by respiratory exercise in the home setting. Am J Hypertens 2004; 17: 370-374.
22. Elliott WJ, Izzo Jr JL. Device-guided breathing to lower blood pressure: case report and clinical overview. MedGenMed 2006; 8: 23 (www.medscape.com/viewarticle/539099).
23. Logtenberg SJ, Kleefstra N, Houweling ST, Groenier KH, Bilo HJ. Effect of device-guided breathing exercises on blood pressure in hypertensive patients with type 2 diabetes mellitus: A randomized controlled trial. J Hypertens 2007; 25: 241-246.
24. Simon RM. Design and analysis of therapeutic equivalence trials. In: Geller NL (ed). Advances in Clinical Trials Biostatistics. Marcel Dekker: New York, 2004, pp 53-66.
25. Gavish B. Device-guided slow breathing as a nonpharmacological approach to antihypertensive treatment in type 2 diabetics. J Hypertens 2007; 25: 1742.
26. Rogers MAM, Small D, Buchan DA, Butch CA, Stewart CM, Krenzer BE et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension: A randomized controlled trial. Ann Intern Med 2001; 134: 1024-1032.
27. Dengel DR, Galecki AT, Hagberg JM, Pratley RE. The independent and combined effects of weight loss and aerobic exercise on blood pressure and oral glucose tolerance in older men. Am J Hypertens 1998; 11: 1405-1412.
28. Hollies S, Campbell F. What is meant by intention to treat analysis. Survey of published randomized controlled trials. BMJ 1999; 319 670-674.
29. Blackwelder WC. Equivalence trials. In: Armitage P, Colton T (eds). Encyclopedia of Biostatistics, vol. 2, John Wiley: Chichester, 1998, pp 1367-1372.
30. Moran A, Palmas W, Field L, Bhattarai J, Schwartz JE, Weinstock RS et al. Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 2004; 27: 972-977.
31. Wirta OR, Pasternack AI, Mustonen JT, Laippala PJ, Reinikainen PM. Urinary albumin excretion rate is independently related to autonomic neuropathy in type 2 diabetes mellitus. J Intern Med 1999; 245 329-335.
32. Bae JH, Kim JH, Choe K-H, Hong SP, Ko JK, Kim CH et al. Effect of device-guided breathing exercise on blood pressure control: Korean multi-center study. Korean Hyperten J 2006; 1: 19-23 (in Korean).
33. de Daly MB. Interactions between respiration and circulation. In: Cheniack NS, Widdicombe JG (eds). Handbook of Physiology. American Physiological Society: Bethesda, 1986, pp 529-594.
34. Eckberg DL, Kifle YT, Roberts VL. Phase relationship between normal human respiration and baroreflex responsiveness. J Physiol 1980; 304: 489-502.
35. Eckberg DL, Nerhed C, Wallin BG. Respiratory modulation of muscle sympathetic and vagal cardiac outflow in man. J Physiol 1985; 365: 181-196.
36. Parati G, Izzo Jr JL, Gavish B. Respiration and blood pressure. In: Izzo JL, Black HR (eds). Hypertension Primer, 3rd edn, Lippincott, Williams, and Wilkins: Baltimore, 2003, pp 117-120.
37. Goso Y, Asanoi H, Ishise H, Kameyama T, Hirai T, Nozawa T et al. Respiratory modulation of muscle sympathetic nerve activity in patients with chronic heart failure. Circulation 2001; 104: 418-423.
38. Bernardi L, Porta C, Spicuzza L, Bellwon J, Spadacini G, Frey AW et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 2002; 105: 143-145.
39. Parati G, Carretta R. Device-guided slow breathing as a non-pharmacological approach to antihypertensive treatment: Efficacy, problems and perspectives. J Hypertens 2007; 25: 57-61.
40. Staessen JA, Thijs L, Bieniaszewski L, O'Brian ET, Palatini P, Davidson C. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Hypertension 1996; 27: 414-420.